Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2461 AL 2475

Clinical and mechanism advances of neuronal intranuclear inclusion disease

Liu Y, Li H, Liu X, Wang B, Yang H, Wan B, Sun M, Xu X.

Front Aging Neurosci. 2022 Sep 13;14:934725. doi: 10.3389/fnagi.2022.934725. eCollection 2022.

[The role of mercury and arsenic in the etiology and pathogenesis of Parkinson's and Alzheimer's diseases]

Salkov VN, Voronkov DN, Khudoerkov RM.

Arkh Patol. 2022;84(5):59-64. doi: 10.17116/patol20228405159.

How well do you know your dopamine antagonists?

2022 Oct. Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutic Initiatives; 1994–. Letter 139.

Progress in Parkinson's disease animal models of genetic defects: Characteristics and application

Zhang C, Chen S, Li X, Xu Q, Lin Y, Lin F, Yuan M, Zi Y, Cai J.

Biomed Pharmacother. 2022 Nov;155:113768. doi: 10.1016/j.biopha.2022.113768. Epub 2022 Sep 28.

Sex differences in clinical cognitive impairment with Lewy bodies: a Chinese multicenter study

Gan J, Chen Z, Shi Z, Li X, Liu S, Liu Y, Zhu H, Shen L, Zhang G, You Y, Guo Q, Zhang N, Lv Y, Gang B, Yuan J, Ji Y.

Biol Sex Differ. 2022 Oct 1;13(1):55. doi: 10.1186/s13293-022-00464-w.

ACTB gene mutation in combined Dystonia-Deafness syndrome with parkinsonism: Expanding the phenotype and highlighting the long-term GPi DBS outcome

Straccia G, Reale C, Castellani M, Colangelo I, Orunesu E, Meoni S, Moro E, Krack P, Prokisch H, Zech M, Romito LM, Garavaglia B.

Parkinsonism Relat Disord. 2022 Nov;104:3-6. doi: 10.1016/j.parkreldis.2022.09.012. Epub 2022 Sep 24.

Computerized analysis of speech and voice for Parkinson's disease: A systematic review

Ngo QC, Motin MA, Pah ND, Drotár P, Kempster P, Kumar D.

Comput Methods Programs Biomed. 2022 Nov;226:107133. doi: 10.1016/j.cmpb.2022.107133. Epub 2022 Sep 16.

REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease

Ahnaou A, Drinkenburg WHIM.

Neurosci Biobehav Rev. 2022 Dec;143:104897. doi: 10.1016/j.neubiorev.2022.104897. Epub 2022 Sep 29.

Connectivity of the corticostriatal and thalamostriatal systems in normal and parkinsonian states: An update

Martel AC, Galvan A.

Neurobiol Dis. 2022 Nov;174:105878. doi: 10.1016/j.nbd.2022.105878. Epub 2022 Sep 29.

Design of Improved Antidiabetic Drugs: A Journey from Single to Multitarget Agents

Tassopoulou VP, Tzara A, Kourounakis AP.

ChemMedChem. 2022 Dec 5;17(23):e202200320. doi: 10.1002/cmdc.202200320. Epub 2022 Oct 26.

Genetics in parkinson's disease: From better disease understanding to machine learning based precision medicine

Aborageh M, Krawitz P, Fröhlich H.

Front Mol Med. 2022 Oct 3;2:933383. doi: 10.3389/fmmed.2022.933383. eCollection 2022.

Abnormal neural oscillations during gait and dual-task in Parkinson's disease

Nwogo RO, Kammermeier S, Singh A.

Front Syst Neurosci. 2022 Sep 15;16:995375. doi: 10.3389/fnsys.2022.995375. eCollection 2022.

Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms

Zhang S, Ma Y.

World J Psychiatry. 2022 Sep 19;12(9):1127-1140. doi: 10.5498/wjp.v12.i9.1127. eCollection 2022 Sep 19.

Evaluation of retina and microvascular changes in the patient with Parkinson's disease: A systematic review and meta-analysis

Deng Y, Jie C, Wang J, Liu Z, Li Y, Hou X.

Front Med (Lausanne). 2022 Sep 15;9:957700. doi: 10.3389/fmed.2022.957700. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias